XBiotech Inc (XBIT)
6.83
+0.21
(+3.17%)
USD |
NASDAQ |
Nov 22, 16:00
6.88
+0.05
(+0.73%)
After-Hours: 20:00
XBiotech Total Liabilities (Quarterly): 17.74M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 17.74M |
| June 30, 2024 | 18.85M |
| March 31, 2024 | 18.58M |
| December 31, 2023 | 7.769M |
| September 30, 2023 | 6.94M |
| June 30, 2023 | 6.073M |
| March 31, 2023 | 5.216M |
| December 31, 2022 | 5.701M |
| September 30, 2022 | 6.025M |
| June 30, 2022 | 10.67M |
| March 31, 2022 | 5.243M |
| December 31, 2021 | 5.792M |
| September 30, 2021 | 5.362M |
| June 30, 2021 | 5.392M |
| March 31, 2021 | 3.842M |
| December 31, 2020 | 5.105M |
| September 30, 2020 | 7.254M |
| June 30, 2020 | 15.19M |
| March 31, 2020 | 11.29M |
| December 31, 2019 | 61.25M |
| September 30, 2019 | 2.021M |
| Date | Value |
|---|---|
| June 30, 2019 | 2.462M |
| March 31, 2019 | 2.841M |
| December 31, 2018 | 2.947M |
| September 30, 2018 | 2.307M |
| June 30, 2018 | 2.768M |
| March 31, 2018 | 2.45M |
| December 31, 2017 | 2.81M |
| September 30, 2017 | 3.522M |
| June 30, 2017 | 4.685M |
| March 31, 2017 | 5.346M |
| December 31, 2016 | 7.986M |
| September 30, 2016 | 6.663M |
| June 30, 2016 | 10.40M |
| March 31, 2016 | 6.583M |
| December 31, 2015 | 6.308M |
| September 30, 2015 | 4.97M |
| June 30, 2015 | 2.872M |
| March 31, 2015 | 3.828M |
| December 31, 2014 | 3.147M |
| September 30, 2014 | 2.443M |
| December 31, 2013 | 0.845M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.842M
Minimum
Mar 2021
61.25M
Maximum
Dec 2019
11.46M
Average
6.506M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
| Oragenics Inc | 2.126M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 209.85M |
| Shareholders Equity (Quarterly) | 192.12M |